Jinyu Bio-Technology Co Ltd (600201)

Currency in CNY
9.64
+0.16(+1.69%)
Closed·
600201 Scorecard
Full Analysis
Management has been aggressively buying back shares
Trading near 52-week High
600201 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.409.74
52 wk Range
6.249.74
Key Statistics
Bid/Ask
9.63 / 9.64
Prev. Close
9.48
Open
9.42
Day's Range
9.4-9.74
52 wk Range
6.24-9.74
Volume
41.24M
Average Volume (3m)
39.77M
1-Year Change
32.05%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600201 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.83
Downside
-8.44%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Jinyu Bio-Technology Co Ltd Company Profile

Jinyu Bio-technology Co., Ltd. manufacturing and sales of veterinary biological drugs in China. The company offers various pig vaccines, including combined porcine circovirus type 2 and mycoplasma pneumoniae, classical swine fever, combined transmissible gastroenteritis and porcine epidemic diarrhea, swine influenza bivalent, porcine reproductive and respiratory syndrome, pseudorabies thermo-stable, porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 baculovirus vector, combined transmissible gastroenteritis and porcine epidemic diarrhea, swine foot and mouth disease bivalent, porcine parvovirus, pseudorabies, haemophilus parasuis trivalent, and porcine circovirus type 2 vaccines. It also provides ruminant vaccines, such as foot and mouth disease trivalent, bovine pasteurella multocida, combined bovine viral diarrhea disease and infectious bovine rhinotracheitis, brucella gene deletion, goat pox, brucellosi, brucellosis, foot and mouth disease bivalent and type O, clostridium chauvoei, lumpy skin disease, combined ovine infectious necrotic hepatitis and braxy, and caprine infectious pleuropneumonia, as well as combined ovine braxy, struck, lamb dysentery, enterotoxaemia, and black disease and clostridium botulinum toxonosis vaccines. In addition, the company offers avian vaccines; rabies vaccines; and PCR and Elisa diagnostic kits. Further, it is involved in manufacturing and sales of veterinary chemical preparations, chemical reagents and auxiliary agents, biological drug preparations, and advanced medical equipment and instruments; biotechnology development, transfer, and consulting services; import and export of goods and technology; and provision of property management services. The company was founded in 1992 and is headquartered in Hohhot, China.

Employees
1740
Market
China

Compare 600201 to Peers and Sector

Metrics to compare
600201
Peers
Sector
Relationship
P/E Ratio
229.8x33.0x−0.6x
PEG Ratio
−2.800.630.00
Price/Book
2.0x2.2x2.6x
Price / LTM Sales
8.5x7.0x3.4x
Upside (Analyst Target)
−11.8%17.9%35.5%
Fair Value Upside
Unlock8.7%3.7%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.83
(-8.44% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.04%
Dividend Yield
0.31%
Industry Median 1.40%
Annualised payout
0.03
Paid unevenly
5-Years Growth
-12.94%
Growth Streak

Earnings

Latest Release
Aug 20, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
268.00M / --
EPS Revisions
Last 90 days

600201 Income Statement

People Also Watch

42.31
YUMC
-1.14%
40.71
002008
-1.24%
28.51
BILI
-1.32%
286.14
ORCL
-0.91%

FAQ

What Stock Exchange Does Jinyu Bio-Tech Trade On?

Jinyu Bio-Tech is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Jinyu Bio-Tech?

The stock symbol for Jinyu Bio-Tech is "600201."

What Is the Jinyu Bio-Tech Market Cap?

As of today, Jinyu Bio-Tech market cap is 10.69B.

What Is Jinyu Bio-Tech's Earnings Per Share (TTM)?

The Jinyu Bio-Tech EPS (TTM) is 0.04.

When Is the Next Jinyu Bio-Tech Earnings Date?

Jinyu Bio-Tech will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is 600201 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Jinyu Bio-Tech Stock Split?

Jinyu Bio-Tech has split 6 times.

How Many Employees Does Jinyu Bio-Tech Have?

Jinyu Bio-Tech has 1740 employees.

What is the current trading status of Jinyu Bio-Tech (600201)?

As of 05 Oct 2025, Jinyu Bio-Tech (600201) is trading at a price of 9.64, with a previous close of 9.48. The stock has fluctuated within a day range of 9.40 to 9.74, while its 52-week range spans from 6.24 to 9.74.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.